🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if MGAH22 is safe when given by i...
Status
Completed
Location
National Cancer Institute
Start Date
2010-07
Trial ID
NCT01148849
Treatments Being Tested
This main purpose of this clinical study is to learn about the safety and a...
Status
Completed
Location
Yale School of Medicine
Start Date
2016-01
Trial ID
NCT02689284
Treatments Being Tested
The purpose of this study is to determine if margetuximab is effective in t...
Status
Completed
Location
University of California San Francisco
Start Date
2013-03
Trial ID
NCT01828021
Treatments Being Tested
The purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-AB...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-04-16
Trial ID
NCT06828588
Treatments Being Tested
This is an open-label, Single-arm, Phase I clinical study to evaluate the p...
Status
Completed
Location
The fifth medical center of the General Hospital of people's Liberation Army of China
Start Date
2020-08-25
Trial ID
NCT04398108
Treatments Being Tested
The purpose of this study is to determine whether patients with metastatic ...
Status
Completed
Location
Ironwood Cancer & Research Center
Start Date
2015-08-24
Trial ID
NCT02492711
Treatments Being Tested
This is a Phase 2/3, randomized, open-label study for the treatment of pati...
Status
Completed
Location
Mayo Clinic - Scottsdale
Start Date
2019-09-30
Trial ID
NCT04082364
Treatments Being Tested
The purpose of the Expanded Access program is to provide margetuximab to pa...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03133988
Treatments Being Tested
This is a multicenter, open-label, single-arm, phase II clinical trial to e...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05-15
Trial ID
NCT05227131
Treatments Being Tested
This is a randomized, open-label, multi-center, Phase II clinical study to ...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-01-13
Trial ID
NCT04262804